Source: Eur Respir J, 49 (6) 1601838; 10.1183/13993003.01838-2016
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Jules L. Derks, Robert Jan van Suylen, Erik Thunnissen, Michael A. den Bakker, Harry J. Groen, Egbert F. Smit, Ronald A. Damhuis, Esther C. van den Broek, Ernst-Jan M. Speel, Anne-Marie C. Dingemans. Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?. Eur Respir J, 49 (6) 1601838; 10.1183/13993003.01838-2016

Member's Comments

No comment yet.

Related content which might interest you: Large cell neuroendocrine carcinoma of the lung: chemotherapy regimen depends on how “large” your diagnostic criteria are Source: Eur Respir J, 50 (4) 1701292; 10.1183/13993003.01292-2017 Year: 2017 Treatment of extensive-stage small cell lung carcinoma: current status and future prospects Source: Eur Respir J 2010; 35: 202-215 Year: 2010 Management of extensive disease-small cell lung cancer Source: Eur Respir Mon; 2009: 44: 310–317 Year: 2009 Large cell neuroendocrine carcinoma of the lung: Experience with 20 resected cases Source: Eur Respir J 2003; 22: Suppl. 45, 250s Year: 2003 Radiotherapy vs. radio-chemotherapy of the inoperable non small cell lung cancer - a phase-III-study Source: Eur Respir J 2001; 18: Suppl. 33, 318s Year: 2001 Neuroendocrine and biologic features of primary tumors and tissue in pulmonary large cell carcinomas Source: Eur Respir J 2004; 24: Suppl. 48, 557s Year: 2004 Chemotherapy in advanced non small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 77s Year: 2005 Radiotherapy in small cell lung cancer: patient options Source: Virtual Congress 2020 – Thoracic oncology Year: 2020 Should there be a specific management for large cell neuroendocrine carcinoma? Source: Annual Congress 2005 - Neuroendocrine tumours of the lung Year: 2005 Clinicopathological prognostic factors in operated for small cell lung carcinoma or large cell neuroendocrine carcinoma patients Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013 Clinical course of asymptomatic small enhancing brain nodules in patients with nonsmall cell lung cancer: do we have to follow them up? Source: ERJ Open Res, 6 (3) 00109-2020; 10.1183/23120541.00109-2020 Year: 2020 Chemotherapy for small cell lung cancer Source: Annual Congress 2006 - PG12 - Small cell lung cancer management Year: 2006 Treatment of limited disease-small cell lung cancer Source: Eur Respir Mon; 2009: 44: 299–309 Year: 2009 Pulmonary metastases from renal cell carcinoma: indications and results Source: Eur Respir J 2002; 20: Suppl. 38, 39s Year: 2002 Long-term survival of the patients with advanced non small cell lung carcinomas after induction chemotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 78s Year: 2005 Efficacy of a toxicity-adjusted topotecan therapy in recurrent small cell lung cancer Source: Eur Respir J 2006; 27: 1183-1189 Year: 2006 Lymphoepithelioma-like carcinoma of the lung in a patient withsilicosis Source: Eur Respir J 2003; 22: 383-386 Year: 2003 Survival of patients with relapsing small cell lung cancer (SCLC) after new line chemotherapy administration Source: Eur Respir J 2005; 26: Suppl. 49, 78s Year: 2005